Pure Global AI
ANVISA registration 10287411737Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 10287411737ROCHE DIAGNÓSTICA BRASIL LTDALUMIRADX UK LTDRisk Class II
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Família LumiraDx HbA1c
Risk class
Class II
Registration details
Registration Number
10287411737
Process Number
25351015814202556
CNPJ
30280358000186
Company information
Manufacturer
LUMIRADX UK LTD
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Mar 05, 2025
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411737 and manufactured by LUMIRADX UK LTD. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.